Drug
Budesonide/Formoterol Fumarate Dihydrate Inhalation Aerosol clinical trials
- studies test it
- 12
- open now
- 0
- in phase 3
- 5
- first study started
- 2006
How studies write it
Studies that test it under each name
Studies by the year they started
12 studies that test it; most in 2007 (2)
| Year | Studies |
|---|---|
| 2006 | 1 |
| 2007 | 2 |
| 2009 | 2 |
| 2010 | 2 |
| 2011 | 1 |
| 2012 | 1 |
| 2018 | 2 |
| 2024 | 1 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 3
- Phase 3
- 5
- Phase 4
- 4
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 8 · Other 4
AstraZeneca (6) · Zhujiang Hospital (2) · Shanghai Xin Huanghe Pharmaceutical Co., Ltd. (1) · British Columbia Cancer Agency (1) · Orion Corporation, Orion Pharma (1) · The First Affiliated Hospital of Guangzhou Medical University (1)
Often tested with
Tested in the same studies.
Budesonide (1) · Conventional Therapy (1) · Montelukast (1)
Studies
Open first, then newest update. How each study uses Budesonide/Formoterol Fumarate Dihydrate Inhalation Aerosol is read from its arms, and is right about nine times in ten.
Testing it · 12
- Bioequivalence Study of Budesonide/Formoterol Inhalation Powder in Healthy ParticipantsCompletedPhase 1Shanghai Xin Huanghe Pharmaceutical Co., Ltd.NCT07804303Written as Budesonide and Formoterol Fumarate Powder for Inhalation (II) (Reference)
- Differences of Small Airways Function Between Chronic Obstructive Pulmonary Disease(COPD) and Asthma-copd Overlap(ACO)Status unknownPhase 4Zhujiang HospitalNCT03563001Written as Budesonide(160ug) and Formoterol(4.5ug) bid
- Change of Lung Function After Exercise in Patients With Chronic Obstructive Pulmonary DiseaseStatus unknownPhase 4Zhujiang HospitalNCT03551197Written as Budesonide and formoterol bid
- Efficacy and Tolerability of Symbicort as an add-on Treatment to Spiriva Compare With Spiriva Alone in Patients With Severe Chronic Obstructive Pulmonary Disease (COPD)CompletedPhase 4AstraZenecaNCT01397890Written as Budesonide/formoterol (Symbicort® Turbuhaler®)
- Effects of Leukotriene Modulator Montelukast on Cough Variant AsthmaStatus unknownPhase 4The First Affiliated Hospital of Guangzhou Medical UniversityNCT01404013Written as ICS/LABA
- A Safety and Efficacy Study of Symbicort Turbuhaler Compared With Standard Chronic Obstructive Pulmonary Disease (COPD) Treatment in JapanCompletedPhase 3AstraZenecaNCT01070784Written as Symbicort Turbuhaler (Budesonide/formoterol)
- Efficacy and Safety Study of Symbicort® Turbuhaler® Versus Oxis® Turbuhaler® in Chronic Obstructive Pulmonary Disease (COPD) PatientsCompletedPhase 3AstraZenecaNCT01069289Written as Budesonide/formoterol (Symbicort Turbuhaler)
- Study to Investigate the Safety and Efficacy of High Dose of Symbicort® SMART in Japanese PatientsCompletedPhase 3AstraZenecaNCT00837967Written as Symbicort Turbuhaler
- Symbicort Rapihaler Therapeutic Equivalence StudyCompletedPhase 3AstraZenecaNCT00536731Written as Symbicort Turbuhaler
- Studying Genes in Blood and Lung Fluid Samples From Patients With Chronic Obstructive Pulmonary Disease With or Without a Previous Diagnosis of Lung Cancer or With Asthma Treated With Budesonide and FormoterolCompletedPhase 1British Columbia Cancer AgencyNCT00569712Written as budesonide/formoterol fumarate dihydrate inhalation aerosol
- Symbicort Single Inhaler Therapy vs Conventional Best Practice for the Treatment of Persistent Asthma in AdultsTerminatedPhase 3AstraZenecaNCT00385593Written as Symbicort (budesonide/formoterol) Turbuhaler
- Pharmacokinetic Pilot Study on Budesonide/Formoterol Device-metered Dry Powder InhalerCompletedPhase 1Orion Corporation, Orion PharmaNCT00868426Written as Budesonide/Formoterol Batch 1
Given in every arm · 2 — Budesonide/Formoterol Fumarate Dihydrate Inhalation Aerosol is usual care beside what is tested
- Study of Bosentan in the Treatment of Stable Severe Chronic Obstructive Pulmonary Disease PatientsStatus unknownPhase 2Air Force Military Medical University, ChinaNCT02093195Written as Symbicort turbuhaler
- Study to Investigate the Efficacy of Symbicort® SMART.CompletedPhase 3AstraZenecaNCT00839800Written as Symbicort Turbuhaler
As the comparator · 5 — what is tested is compared with Budesonide/Formoterol Fumarate Dihydrate Inhalation Aerosol
- Study Comparing Dual Combination of Product (Budesonide and Formoterol) Given Via Two Different Inhalers. To See Which One Results in the Best Effect on Breathing.CompletedPhase 3AstraZenecaNCT04078126Written as Symbicort Turbuhaler
- Study to Assess Efficacy and Safety of PT009 Compared to PT005, PT008, and Symbicort® Turbuhaler® on Lung Function Over 24-Weeks in Subjects With Moderate to Very Severe COPDCompletedPhase 3Pearl Therapeutics, Inc.NCT02766608Written as Symbicort® TBH 400/12 μg BID
- Pharmacokinetic Study to Compare Absorption of Budesonide/Formoterol Easyhaler and Symbicort TurbuhalerCompletedPhase 1Orion Corporation, Orion PharmaNCT03073057Written as Symbicort Turbuhaler
- Comparison of Absorption of Budesonide and Formoterol From Budesonide/Formoterol Easyhaler and Symbicort TurbuhalerCompletedPhase 1Orion Corporation, Orion PharmaNCT01593826Written as Charcoal and Symbicort Turbuhaler
- Pharmacokinetic Study Comparing Budesonide/Formoterol Easyhaler and Symbicort Turbuhaler ForteCompletedPhase 1Orion Corporation, Orion PharmaNCT01627158Written as Symbicort Turbuhaler